AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Journal of Neurorestoratology Article
PDF (721.8 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

The 2019 yearbook of Neurorestoratology

Hongyun Huang1,2( ), Lin Chen3, Gengsheng Mao1, John Bach4, Qun Xue5, Fabin Han6, Xiaoling Guo7, Ali Otom8, Elena Chernykh9, Edgardo Alvarez10, Andrey Bryukhovetskiy11, Anna Sarnowaska12, Xijing He13, Milan Dimitrijevic14, Ihsan Shanti15, Klaus von Wild16, Almudena Ramón-Cueto17, Ziad Alzoubi18, Gustavo Moviglia19, Hamid Mobasheri20, Adeeb Alzoubi21, Wenchuan Zhang22
Institute of Neurorestoratology, Third Medical Center of General Hospital of PLA, Beijing, China
Cell Therapy Center, Beijing Hongtianji Neuroscience Academy, Beijing, China
Department of Neurorestoratology, Tsinghua University Yuquan Hospital, Beijing, China
Center for Ventilator Management Alternatives, University Hospital, Newark, New Jersey, USA
Neurology Department, the First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu, China;
The Institute for Translational Medicine, Affiliated Second Hospital and Liaocheng Hospital in Shandong University, Liaocheng, China;
Neurological Center, 981 Hospital of PLA, Chengde, Hebei, China;
Royal Specialty Center for Spine & M-Skeletal Disorders, Amman, Jordan;
Lab of Cellular Immunotherapy and Institute of Fundamental and Clinical Immunology, Novosibirs, Russia.;
Laboratory of Experimental Neuropsychopharmacology, Medical Sciences, National University of Cuyo, Mendoza, Argentina;
Central Clinical Hospital of the Russian Academy of Science, Russia;
Translational Platform for Regenerative Medicine (PBTMR), Polish Academy of Sciences, Warsaw, Poland;
Xi’an International Rehabilitation Medical Center, Xi’an, Shaanxi, China;
Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, Texas, USA;
American Clinic for Interventional Pain and Spine, Amman, Jordan;
Department of Neurosurgery, Westphalia Wilhelm’s University, Münster, Germany;
Center for Medical Innovation in Medullary Regeneration (CIMERM), Spain;
Jordan Orthopedic and Spine Center, Amman, Jordan;
Wake Forest Institute for Regenerative Medicine of Wake Forest University, North Caroline, USA;
Laboratory of Membrane Biophysics and Macromolecules, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran;
Stem Cells Arabia, Amman, Jordan;
Department of Neurosurgery, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China
Show Author Information

Abstract

Time is infinite movement in constant motion. We are glad to see that Neurorestoratology, a new discipline, has grown into a rich field involving many global researchers in recent years. In this 2019 yearbook of Neurorestoratology, we introduce the most recent advances and achievements in this field, including findings on the pathogenesis of neurological diseases, neurorestorative mechanisms, and clinical therapeutic achievements globally. Many patients have benefited from treatments involving cell therapies, neurostimulation/neuromodulation, brain–computer interface, neurorestorative surgery or pharmacy, and many others. Clinical physicians can refer to this yearbook with the latest knowledge and apply it to clinical practice.

Keywords

yearbookNeurorestoratologypathogenesisneurorestorative mechanismtherapeutic achievement

References

[1]
D Zada, I Bronshtein, T Lerer-Goldshtein, et al. Sleep increases chromosome dynamics to enable reduction of accumulating DNA damage in single neurons. Nat Commun. 2019, 10(1): 895.
Crossref Google Scholar
[2]
EP Moreno-Jiménez, M Flor-García, J Terreros-Roncal, et al. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. Nat Med. 2019, 25(4): 554-560.
Crossref Google Scholar
[3]
MK Tobin, K Musaraca, A Disouky, et al. Human hippocampal neurogenesis persists in aged adults and Alzheimer’s disease patients. Cell Stem Cell. 2019, 24(6): 974-982.e3.
Crossref Google Scholar
[4]
H Mathys, J Davila-Velderrain, ZY Peng, et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature. 2019, 570(7761): 332-337.
Crossref Google Scholar
[5]
C Ising, C Venegas, SS Zhang, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019, 575(7784): 669-673.
Crossref Google Scholar
[6]
SS Dominy, C Lynch, F Ermini, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019, 5(1):eaau3333.
Google Scholar
[7]
MV Lourenco, RL Frozza, GB de Freitas, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat Med. 2019, 25(1): 165-175.
Crossref Google Scholar
[8]
Z Vrselja, SG Daniele, J Silbereis, et al. Restoration of brain circulation and cellular functions hours post- mortem. Nature. 2019, 568(7752): 336-343.
Crossref Google Scholar
[9]
GK Anumanchipalli, J Chartier, EF Chang. Speech synthesis from neural decoding of spoken sentences. Nature. 2019, 568(7753): 493-498.
Crossref Google Scholar
[10]
RN Moda-Sava, MH Murdock, PK Parekh, et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science. 2019, 364(6436): eaat8078.
Google Scholar
[11]
BL Heckmann, BJW Teubner, B Tummers, et al. LC3-associated endocytosis facilitates β-amyloid clearance and mitigates neurodegeneration in murine Alzheimer’s disease. Cell. 2019, 178(3): 536-551.e14.
Crossref Google Scholar
[12]
NE Fultz, G Bonmassar, K Setsompop, et al. Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science. 2019, 366(6465): 628-631.
Crossref Google Scholar
[13]
T von Wild, GA Brunelli, KRH von Wild, et al. Regeneration of denervated skeletal muscles – brunelli’s CNS-PNS paradigm. J Med Life. 2019, 12(4): 342-353.
Google Scholar
[14]
ML Levy, JR Crawford, N Dib, et al. Phase I/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke. Stroke. 2019, 50(10): 2835-2841.
Crossref Google Scholar
[15]
GZ Zhang, Y Li, JL Reuss, et al. Stable intracerebral transplantation of neural stem cells for the treatment of paralysis due to ischemic stroke. Stem Cells Transl Med. 2019, 8(10): 999-1007.
Crossref Google Scholar
[16]
XL Guo, X Wang, Y Li, et al. Olfactory ensheathing cell transplantation improving cerebral infarction sequela: a case report and literature review. J Neurorestoratology. 2019, 7(2): 82-88.
Crossref Google Scholar
[17]
SI Savitz, D Yavagal, G Rappard, et al. A phase 2 randomized, sham-controlled trial of internal carotid artery infusion of autologous bone marrow-derived ALD-401 cells in patients with recent stable ischemic stroke (RECOVER-stroke). Circulation. 2019, 139(2): 192-205.
Crossref Google Scholar
[18]
MC Brunet, SH Chen, P Khandelwal, et al. Intravenous stem cell therapy for high-grade aneurysmal subarachnoid hemorrhage: case report and literature review. World Neurosurg. 2019, 128: 573-575.
Crossref Google Scholar
[19]
AMA Hammadi, F Alhimyari. Intra-arterial injection of autologous bone marrow-derived mononuclear cells in ischemic stroke patients. Exp Clin Transplant. 2019, 17(Suppl 1): 239-241.
Crossref Google Scholar
[20]
FS Vahidy, ME Haque, MH Rahbar, et al. Intravenous bone marrow mononuclear cells for acute ischemic stroke: safety, feasibility, and effect size from a phase I clinical trial. Stem Cells. 2019, 37(11): 1481-1491.
Crossref Google Scholar
[21]
J Vaquero, M Zurita, J Mucientes, et al. Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer’s type dementia. Cytotherapy. 2019, 21(4): 428-432.
Crossref Google Scholar
[22]
AD Levi, KD Anderson, DO Okonkwo, et al. Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury. J Neurotrauma. 2019, 36(6): 891-902.
Crossref Google Scholar
[23]
M Bydon, AB Dietz, S Goncalves, et al. CELLTOP clinical trial: first report from a phase 1 trial of autologous adipose tissue-derived mesenchymal stem cells in the treatment of paralysis due to traumatic spinal cord injury. Mayo Clin Proc. 2020, 95(2): 406-414.
Crossref Google Scholar
[24]
P Phedy, YP Djaja, L Gatam, et al. Motoric recovery after transplantation of bone marrow derived mesenchymal stem cells in chronic spinal cord injury: a case report. Am J Case Rep. 2019, 20: 1299-1304.
Crossref Google Scholar
[25]
JJ Moore, JC Massey, CD Ford, et al. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis. J Neurol Neurosurg Psychiatry. 2019, 90(5): 514-521.
Crossref Google Scholar
[26]
A Mariottini, C Innocenti, B Forci, et al. Safety and efficacy of autologous hematopoietic stem-cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis. Eur J Neurol. 2019, 26(4): 624-630.
Crossref Google Scholar
[27]
D Boruczkowski, I Zdolińska-Malinowska. Wharton’s jelly mesenchymal stem cell administration improves quality of life and self-sufficiency in children with cerebral palsy: results from a retrospective study. Stem Cells Int. 2019, 2019: 1-13.
Crossref Google Scholar
[28]
D Boruczkowski, I Zdolińska-Malinowska. A retrospective analysis of safety and efficacy of Wharton’s jelly stem cell administration in children with spina bifida. Stem Cell Rev And Rep. 2019, 15(5): 717-729.
Crossref Google Scholar
[29]
K Pan, LN Deng, PY Chen, et al. Safety and feasibility of repeated intrathecal allogeneic bone marrow-derived mesenchymal stromal cells in patients with neurological diseases. Stem Cells Int. 2019, 2019: 8421281.
Crossref Google Scholar
[30]
C Goudie, AM Alayoubi, P Tibout, et al. Hematopoietic stem cell transplant does not prevent neurological deterioration in infants with Farber disease: Case report and literature review. JIMD Rep. 2019, 46(1): 46-51.
Google Scholar
[31]
Y Chen, XH Zhang, LP Xu, et al. Haploidentical allogenetic hematopoietic stem cell transplantation for X-linked adrenoleukodystrophy (in Chinese). Beijing Da Xue Xue Bao Yi Xue Ban. 2019, 51(3):409-413.
Google Scholar
[32]
NH Riordan, ML Hincapié, I Morales, et al. Allogeneic human umbilical cord mesenchymal stem cells for the treatment of autism spectrum disorder in children: safety profile and effect on cytokine levels. Stem Cells Transl Med. 2019, 8(10): 1008-1016.
Crossref Google Scholar
[33]
B Blok, P van Kerrebroeck, S de Wachter, et al. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study. Neurourol Urodyn. 2019, 38(2): 689-695.
Crossref Google Scholar
[34]
R McCrery, F Lane, K Benson, et al. Treatment of urinary urgency incontinence using a rechargeable SNM system: 6-month results of the ARTISAN-SNM study. J Urol. 2020, 203(1): 185-192.
Crossref Google Scholar
[35]
SD Yeh, BS Lin, SC Chen, et al. Effects of genital nerve stimulation amplitude on bladder capacity in spinal cord injured subjects. Evid Based Complement Alternat Med. 2019, 2019: 1248342.
Crossref Google Scholar
[36]
DJ Bourbeau, KJ Gustafson, SW Brose. At-home genital nerve stimulation for individuals with SCI and neurogenic detrusor overactivity: a pilot feasibility study. J Spinal Cord Med. 2019, 42(3): 360-370.
Crossref Google Scholar
[37]
AL Benabid, T Costecalde, A Eliseyev, et al. An exoskeleton controlled by an epidural wireless brain- machine interface in a tetraplegic patient: a proof-of- concept demonstration. Lancet Neurol. 2019, 18(12): 1112-1122.
Crossref Google Scholar
[38]
M Bockbrader, N Annetta, D Friedenberg, et al. Clinically significant gains in skillful grasp coordination by an individual with tetraplegia using an implanted brain-computer interface with forearm transcutaneous muscle stimulation. Arch Phys Med Rehabil. 2019, 100(7): 1201-1217.
Crossref Google Scholar
[39]
M Seier, A Hiller, J Quinn, et al. Alternating thalamic deep brain stimulation for essential tremor: a trial to reduce habituation. Mov Disord Clin Pract. 2018, 5(6): 620-626.
Crossref Google Scholar
[40]
A Selfslagh, S Shokur, DSF Campos, et al. Non- invasive, brain-controlled functional electrical stimulation for locomotion rehabilitation in individuals with paraplegia. Sci Rep. 2019, 9(1): 6782.
Crossref Google Scholar
[41]
SY Fan, KL Wang, W Hu, et al. Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia. Ann Clin Transl Neurol. 2020, 7(1): 59-68.
Crossref Google Scholar
[42]
R Krauth, J Schwertner, S Vogt, et al. Cortico-muscular coherence is reduced acutely post-stroke and increases bilaterally during motor recovery: a pilot study. Front Neurol. 2019, 10: 126.
Crossref Google Scholar
[43]
DJ Yang, Q Wang, CP Xu, et al. Transcranial direct current stimulation reduces seizure frequency in patients with refractory focal epilepsy: a randomized, double- blind, sham-controlled, and three-arm parallel multicenter study. Brain Stimul. 2020, 13(1): 109-116.
Crossref Google Scholar
[44]
C Elder, D Friedman, O Devinsky, et al. Responsive neurostimulation targeting the anterior nucleus of the thalamus in 3 patients with treatment-resistant multifocal epilepsy. Epilepsia Open. 2019, 4(1): 187-192.
Crossref Google Scholar
[45]
BF Yu, YQ Qiu, MX Du, et al. Contralateral hemi- fifth-lumbar nerve transfer for unilateral lower limb dysfunction due to incomplete traumatic spinal cord injury: a report of two cases. Microsurgery. 2020, 40(2): 234-240.
Crossref Google Scholar
[46]
N van Zyl, B Hill, C Cooper, et al. Expanding traditional tendon-based techniques with nerve transfers for the restoration of upper limb function in tetraplegia: a prospective case series. Lancet. 2019, 394(10198): 565-575.
Crossref Google Scholar
[47]
JM Khalifeh, CF Dibble, A van Voorhis, et al. Nerve transfers in the upper extremity following cervical spinal cord injury. Part 2: Preliminary results of a prospective clinical trial. J Neurosurg Spine. 2019: 1-13.
Crossref Google Scholar
[48]
CF Dibble, JM Khalifeh, A VanVoorhis, et al. Novel nerve transfers for motor and sensory restoration in high cervical spinal cord injury. World Neurosurg. 2019, 128: 611-615.e1.
Crossref Google Scholar
[49]
WB Ding, S Zhang, D Wu, et al. Hand function recovery using nerve segment insert grafting in patients with chronic incomplete lower cervical spinal cord injury: a preliminary clinical report. J Neurorestoratology. 2019, 7(3): 129-135.
Crossref Google Scholar
[50]
YQ Qiu, MX Du, BF Yu, et al. Contralateral lumbar to sacral nerve rerouting for hemiplegic patients after stroke: a clinical pilot study. World Neurosurg. 2019, 121: 12-18.
Crossref Google Scholar
[51]
JY Guan, J Lin, XQ Guan, et al. Treatment of central paralysis of upper extremity using contralateral C7 nerve transfer via posterior spinal route. World Neurosurg. 2019, 125: 228-233.
Crossref Google Scholar
[52]
FR Wu, CY Ng. Sensory nerve transfer for lower roots brachial plexus injury: superficial radial nerve to the dorsal cutaneous branch and the superficial branch of the ulnar nerve. J Hand Microsurg. 2019, 11(3): 178-180.
Crossref Google Scholar
[53]
RY Kannan, A Hills, MJ Shelley, et al. Immediate compared with late repair of extracranial branches of the facial nerve: a comparative study. Br J Oral Maxillofac Surg. 2020, 58(2): 163-169.
Crossref Google Scholar
[54]
JC Zang, SH Qin, P Vigneshwaran, et al. The treatment of neurotrophic foot and ankle deformity of spinal bifida: 248 cases in single center. J Neurorestoratology. 2019, 7(3): 153-160.
Crossref Google Scholar
[55]
WH Jost, L Tatu, S Pandey, et al. Frequency of different subtypes of cervical dystonia: a prospective multicenter study according to Col-Cap concept. J Neural Transm. 2020, 127(1): 45-50.
Crossref Google Scholar
[56]
P Shieh, K Sharma, B Kohrman, et al. Amifampridine phosphate (Firdapse) is effective in a confirmatory phase 3 clinical trial in LEMS. J Clin Neuromuscul Dis. 2019, 20(3): 111-119.
Crossref Google Scholar
[57]
Ma H, Campbell BCV, Parsons MW, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019, 380(19): 1795-1803.
Google Scholar
[58]
JF Howard Jr, V Bril, TM Burns, et al. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis. Neurology. 2019, 92(23): e2661-e2673.
Crossref Google Scholar
[59]
E Shevela, M Davydova, N Starostina, et al. Intranasal delivery of M2 macrophage-derived soluble products reduces neuropsychological deficit in patients with cerebrovascular disease: A pilot study. J Neurorestoratology. 2019, 7(2): 89-100.
Crossref Google Scholar
[60]
CW Christine, KS Bankiewicz, AD van Laar, et al. Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson’s disease. Ann Neurol. 2019, 85(5): 704-714.
Crossref Google Scholar
[61]
JD Heiss, C Lungu, DA Hammoud, et al. Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson’s disease. Mov Disord. 2019, 34(7): 1073-1078.
Crossref Google Scholar
[62]
SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, et al. Targeting huntingtin expression in patients with Huntington’s disease. N Engl J Med. 2019, 380(24): 2307-2316.
Crossref Google Scholar
[63]
J Kim, CG Hu, C Moufawad El Achkar, et al. Patient-customized oligonucleotide therapy for a rare genetic disease. N Engl J Med. 2019, 381(17): 1644- 1652.
Google Scholar
[64]
AL Behrman, LC Argetsinger, MT Roberts, et al. Activity-based therapy targeting neuromuscular capacity after pediatric-onset spinal cord injury. Top Spinal Cord Inj Rehabil. 2019, 25(2): 132-149.
Crossref Google Scholar
[66]
JN Xi, HY Jiang, N Zhang, et al. Respiratory muscle endurance training with normocapnic hyperpnoea for patients with chronic spinal cord injury: a pilot short-term randomized controlled trial. J Rehabil Med. 2019, 51(8): 616-620.
Crossref Google Scholar
[66]
A Berger, F Horst, F Steinberg, et al. Increased gait variability during robot-assisted walking is accompanied by increased sensorimotor brain activity in healthy people. J Neuroeng Rehabil. 2019, 16(1): 161.
Crossref Google Scholar
[67]
YH Wei, DC Du, K Jiang. Therapeutic efficacy of acupuncture combined with neuromuscular joint facilitation in treatment of hemiplegic shoulder pain. World J Clin Cases. 2019, 7(23): 3964-3970.
Crossref Google Scholar
[68]
M Wang, ZL Zhang, X Wang, et al. Clinical trials of acupuncture treatment of post-stroke shoulder pain (in Chinese). Zhen Ci Yan Jiu. 2019, 44(8): 605-609.
Google Scholar
[69]
YX Duan, ZQ Zhang, XJ Luo, et al. Randomized controlled trial of internal heat-type acupuncture needle therapy in the treatment of post-stroke shoulder pain (in Chinese). Zhen Ci Yan Jiu. 2019, 44(3): 205-210.
Google Scholar
[70]
YX Duan, ZQ Zhang, XJ Luo, et al. Short-term and long-term therapeutic effects of internal heat-type acupuncture needle therapy combined with acupoint injection of O3 for post-stroke shoulder pain (in Chinese). Zhen Ci Yan Jiu. 2019, 44(1): 51-56.
Google Scholar
[71]
M Pradines, M Ghedira, R Portero, et al. Ultrasound structural changes in triceps surae after a 1-year daily self-stretch program: a prospective randomized controlled trial in chronic hemiparesis. Neurorehabil Neural Repair. 2019, 33(4): 245-259.
Crossref Google Scholar
[72]
tuğba Atan, Ö Özyemİşcİ Taşkiran, A Bora Tokçaer, et al. Effects of different percentages of body weight- supported treadmill training in Parkinson’s disease: a double-blind randomized controlled trial. Turk J Med Sci. 2019, 49(4): 999-1007.
Crossref Google Scholar
[73]
DJ Edwards, M Cortes, A Rykman-Peltz, et al. Clinical improvement with intensive robot-assisted arm training in chronic stroke is unchanged by supplementary tDCS. Restor Neurol Neurosci. 2019, 37(2): 167-180.
Crossref Google Scholar
[74]
ZY Liao, YL Bu, MJ Li, et al. Remote ischemic conditioning improves cognition in patients with subcortical ischemic vascular dementia. BMC Neurol. 2019, 19(1): 206.
Crossref Google Scholar
[75]
Y Tang, Y Xing, ZD Zhu, et al. The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): a randomized controlled trial. Alzheimers Dement. 2019, 15(5): 605-614.
Crossref Google Scholar
[76]
WJ Zhao, H You, SR Jiang, et al. Effect of Pro-kin visual feedback balance training system on gait stability in patients with cerebral small vessel disease. Medicine (Baltimore). 2019, 98(7): e14503.
Crossref Google Scholar
[77]
J Najar, S Östling, P Gudmundsson, et al. Cognitive and physical activity and dementia: a 44-year longitudinal population study of women. Neurology. 2019, 92(12): e1322-e1330.
Crossref Google Scholar
[78]
JS Rabin, H Klein, DR Kirn, et al. Associations of physical activity and β-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults. JAMA Neurol. 2019, in press, .
Crossref Google Scholar
[79]
J Marusiak, BE Fisher, A Jaskólska, et al. Eight weeks of aerobic interval training improves psychomotor function in patients with Parkinson’s disease-randomized controlled trial. Int J Environ Res Public Health. 2019, 16(5): E880.
Crossref Google Scholar
[80]
NM van der Kolk, NM de Vries, RPC Kessels, et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson’s disease: a double- blind, randomised controlled trial. Lancet Neurol. 2019, 18(11): 998-1008.
Crossref Google Scholar
[81]
L Gao, X Li, DB Wang, et al. Clinical trial of treatment of frozen shoulder by intensive moxibustion plus acupuncture (in Chinese). Zhen Ci Yan Jiu. 2019, 44(4): 297-301.
Google Scholar
[82]
UE Syed, A Kamal. Video game-based and conventional therapies in patients of neurological deficits: an experimental study. Disabil Rehabil Assist Technol. 2019: 1-8.
Google Scholar
[83]
M Puyade, C Labeyrie, M Badoglio, et al. Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) (in French). Bull Cancer. 2020, 107(1S): S104-S113.
Google Scholar
Journal of Neurorestoratology
Volume 8 Issue 1,
March 2020
Pages 1-11
DOI: 10.26599/JNR.2020.9040004
Cite this article:
Huang H, Chen L, Mao G, et al. The 2019 yearbook of Neurorestoratology. Journal of Neurorestoratology, 2020, 8(1): 1-11. https://doi.org/10.26599/JNR.2020.9040004

797

Views

41

Downloads

17

Crossref

32

Web of Science

0

Scopus

Altmetrics
Received: 04 March 2020
Accepted: 10 March 2020
Published: 23 April 2020
© The authors 2020

This article is published with open access at http://jnr.tsinghuajournals.com
Return